Alnylam Pharmaceuticals, Inc. (ALNY)
236.06
-0.16
(-0.07%)
USD |
NASDAQ |
Aug 24, 16:00
237.08
+1.02
(+0.43%)
After-Hours: 19:20
Alnylam Pharmaceuticals Debt to Equity Ratio : 2.206 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.206 |
| March 31, 2026 | 2.762 |
| December 31, 2025 | 3.762 |
| September 30, 2025 | 11.86 |
| June 30, 2025 | 10.93 |
| March 31, 2025 | 23.58 |
| December 31, 2024 | 40.89 |
| September 30, 2024 | 84.26 |
| June 30, 2024 | -883.03 |
| March 31, 2024 | -12.24 |
| December 31, 2023 | -12.16 |
| September 30, 2023 | -16.06 |
| June 30, 2023 | -6.484 |
| March 31, 2023 | -10.14 |
| December 31, 2022 | -16.51 |
| September 30, 2022 | -38.32 |
| June 30, 2022 | 12.69 |
| March 31, 2022 | 5.512 |
| December 31, 2021 | 3.716 |
| September 30, 2021 | 2.539 |
| June 30, 2021 | 2.214 |
| March 31, 2021 | 1.747 |
| December 31, 2020 | 1.567 |
| September 30, 2020 | 1.130 |
| June 30, 2020 | 0.9497 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2258 |
| December 31, 2019 | 0.2112 |
| September 30, 2019 | 0.1895 |
| June 30, 2019 | 0.1915 |
| March 31, 2019 | 0.2129 |
| December 31, 2018 | 0.023 |
| September 30, 2018 | 0.0203 |
| June 30, 2018 | 0.0185 |
| March 31, 2018 | 0.0171 |
| December 31, 2017 | 0.017 |
| September 30, 2017 | 0.1417 |
| June 30, 2017 | 0.1336 |
| March 31, 2017 | 0.1805 |
| December 31, 2016 | 0.163 |
| September 30, 2016 | 0.1478 |
| June 30, 2016 | 0.1366 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ionis Pharmaceuticals, Inc. | 4.978 |
| Regeneron Pharmaceuticals, Inc. | 0.0854 |
| Vertex Pharmaceuticals, Inc. | 0.0977 |
| BridgeBio Pharma, Inc. | -1.353 |
| Pfizer Inc. | 0.7418 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 5.559B |
| Total Liabilities (Quarterly) | 4.205B |
| Shareholders Equity (Quarterly) | 1.354B |
| Current Ratio | 3.055 |
| Net Debt Paydown Yield | -0.13% |